Good ACE, bad ACE do battle in lung injury, SARS
- 1 August 2005
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 11 (8) , 821-822
Abstract
Two studies show how the enzyme ACE2 protects against lung injury caused by SARS and other agents. ACE2 seems to counteract the effects of ACE, which are more damaging (pages 875–879).Keywords
This publication has 13 references indexed in Scilit:
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Angiotensin-converting enzyme 2 protects from severe acute lung failureNature, 2005
- Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entryProceedings of the National Academy of Sciences, 2005
- Aged BALB/c Mice as a Model for Increased Severity of Severe Acute Respiratory Syndrome in Elderly HumansJournal of Virology, 2005
- ACE2: from vasopeptidase to SARS virus receptorTrends in Pharmacological Sciences, 2004
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- Lung pathology of fatal severe acute respiratory syndromeThe Lancet, 2003
- Nonpeptide Antagonists of AT1 Receptor for Angiotensin II Delay the Onset of Acute Respiratory Distress SyndromeThe Journal of Pharmacology and Experimental Therapeutics, 2002
- A further Investigation INTO INFLUENZO-PNEUMOCOCCAL AND INFLUENZO-STREPTOCOCCAL SEPTICÆMIA: EPIDEMIC INFLUENZAL "PNEUMONIA" OF HIGHLY FATAL TYPE AND ITS RELATION TO "PURULENT BRONCHITIS."The Lancet, 1919